about
Genomic structure of the human retinoblastoma-related Rb2/p130 geneUltrasound biomicroscopy in small animal research: applications in molecular and preclinical imaging.Targeting a newly established spontaneous feline fibrosarcoma cell line by gene transferOmega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.Chemo-predictive assay for targeting cancer stem-like cells in patients affected by brain tumors.Transcriptional regulation of HIV-1 gene expression by p53.Interview with the retinoblastoma family members: do they help each other?A novel phantom model for mouse tumor dose assessment under MV beams.Cadmium induces p53-dependent apoptosis in human prostate epithelial cellsp53 and the malignant progression of Barrett's esophagus.Epigenetic information and estrogen receptor alpha expression in breast cancer.Personalizing gene therapy in gastric cancer.Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses?Tumor suppressor genes as cancer therapeutics.Epigenome-derived drugs: recent advances and future perspectives.A new complementary procedure for patients affected by head and neck cancer: Chemo-predictive assay.Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin.Adenoviral gene therapy in high-grade malignant glioma.Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis.Impaired mitochondrial protein synthesis in head and neck squamous cell carcinoma.Microbubble-assisted p53, RB, and p130 gene transfer in combination with radiation therapy in prostate cancer.Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer.Cdk9 phosphorylates p53 on serine 392 independently of CKII.Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A.pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis.Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms.pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation.ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A.A new palatal distractor device for bodily movement of maxillary bones by rigid self-locking miniplates and screws system.Stem cells in cancer therapy: From their role in pathogenesis to their use as therapeutic agents.New palatal distraction device by both bone-borne and tooth-borne force application in a paramedian bone anchorage site: surgical and occlusal considerations on clinical cases.Chin Wing Osteotomy for Bilateral Goldenhar Syndrome Treated by "Chin Wing Mentoplasty": Aesthetic, Functional, and Histological Considerations.Ridge Expansion by Flapless Split Crest and Immediate Implant Placement: Evolution of the Technique.Intraoral epimucosal fixation for reducible maxillary fractures of the jaws; surgical considerations in comparison to current techniques.Application of the primer in situ DNA synthesis (PRINS) technique to titer recombinant virus and evaluation of the efficiency of viral transduction.pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents.pRb2/p130 gene overexpression induces astrocyte differentiation.
P50
Q24602495-90F259F6-0495-410C-B9DC-0AC70FAC1159Q27025201-00B98840-1C3D-40D1-A600-C72C9D2F5530Q28729067-97D3EB58-AEF6-4A73-859B-7E4AFEC69F5BQ31123584-11D2A073-72C6-44EF-958D-D33FEBA19FA0Q33553311-A333C8C5-6904-4DA1-B59D-D66D22FE712DQ33730689-50496716-12A3-4D26-92A9-DE137D296922Q34075672-C9230BD3-874F-4587-B059-7EE06D7DF523Q34620906-0275856C-2EB7-458C-9900-FD552C65BE01Q34736677-BD165268-86B7-4B93-AE29-2473B39FAA46Q35524259-EB328874-B784-4951-8AEB-8179F0B90BE8Q35842539-11C99E45-C2F4-43E9-907A-2A034BD58DEFQ36234837-F7101CCB-3452-48A8-A6EA-CE1853F1FD72Q36364262-1A6FDB05-9DD8-45B5-A062-4B28704D3F8FQ36707239-CBDBB4C6-3F06-4718-BA69-C16F72B740C9Q36945553-0317F73C-3E2F-471B-9AEF-7F8AF8412782Q37031933-257D5A5A-1523-47F4-BE2E-0095E61D18BDQ37095285-8A787C93-C419-4044-BD59-1B7F65BB326FQ37131478-2C51DA03-F335-45A9-9835-F7DC6CB926A5Q37619254-8C01CF38-3C2C-4ED4-A5B1-2486F92A71C8Q37779013-38E9CCE7-350A-4A1A-BBA3-61FEA95CA438Q38363528-311832ED-D9FE-4218-BBE7-CCCC4CF3BEEEQ38846871-1BE9C166-FEA3-484D-B307-1D9FCE27F9BCQ39175356-5E85EF8B-A189-4317-A7CA-2D10872DAEE5Q40228049-B212C590-CA27-4AB8-AE74-994654005F46Q40272241-5BA2C994-FACC-431C-9924-43FF950A82E8Q40568073-673080F5-B25B-4CC7-95FF-5D9B732A720CQ40627909-8ECF0D41-35F6-486A-9A92-A175096BDA4DQ40633701-188C72C8-13BE-40D9-A958-B2D0FA67041FQ40709921-B58664CC-2433-459A-80A6-BB21203CC880Q42829509-FF8A4AFE-13C5-4E87-A23B-040D4185226BQ43542039-1523761D-FF0F-49FE-8532-130D5D9A5AA6Q44956369-FAFEEB5B-2145-4E75-8DF4-3F5D107C96D0Q44994785-0349746B-971E-4931-8F2F-7DEBA3F3F278Q45288818-AD970319-1A23-431A-8EAA-B555785211A9Q45293119-80039540-9B1C-442B-9C04-424F3D13B3EEQ45302289-7650DA43-32AB-481C-A718-1E9EAF11697EQ45738139-C549BA56-EB98-4727-9A30-F59D85FE6C4AQ47433429-F855437A-9F3F-4206-91CD-4C5CE0C02120Q50720637-40E2CE7E-E307-4EB2-B94F-5908FE6DD6A0Q54565805-0846E786-7206-47F9-B024-A1FB4F71CEC9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pier Paolo Claudio
@ast
Pier Paolo Claudio
@en
Pier Paolo Claudio
@es
Pier Paolo Claudio
@nl
Pier Paolo Claudio
@sl
type
label
Pier Paolo Claudio
@ast
Pier Paolo Claudio
@en
Pier Paolo Claudio
@es
Pier Paolo Claudio
@nl
Pier Paolo Claudio
@sl
prefLabel
Pier Paolo Claudio
@ast
Pier Paolo Claudio
@en
Pier Paolo Claudio
@es
Pier Paolo Claudio
@nl
Pier Paolo Claudio
@sl
P106
P1153
35445318600
P21
P31
P496
0000-0001-7790-1622